TGFBR2, transforming growth factor beta receptor 2, 7048
N. diseases: 502; N. variants: 76
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 3 | 30672234 | missense variant | G/C | snv |
|
0.700 | 1.000 | 6 | 2005 | 2016 | ||||||||||
|
1.000 | 3 | 30672234 | missense variant | G/C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 6 | 2005 | 2016 | |||||||||
|
1.000 | 3 | 30688383 | splice acceptor variant | G/A | snv |
|
0.700 | 1.000 | 4 | 2006 | 2010 | ||||||||||
|
1.000 | 3 | 30672361 | missense variant | G/A | snv |
|
0.700 | 1.000 | 2 | 2013 | 2016 | ||||||||||
|
3 | 30632373 | non coding transcript exon variant | C/T | snv | 7.2E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 30632373 | non coding transcript exon variant | C/T | snv | 7.2E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 3 | 30693684 | 3 prime UTR variant | T/A | snv | 4.8E-02 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 3 | 30605668 | upstream gene variant | A/G;T | snv | 0.64 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 3 | 30605668 | upstream gene variant | A/G;T | snv | 0.64 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 3 | 30605668 | upstream gene variant | A/G;T | snv | 0.64 |
|
0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||||
|
3 | 30668751 | intron variant | A/G | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||||
|
3 | 30668751 | intron variant | A/G | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||||
|
3 | 30671823 | missense variant | G/A | snv | 1.4E-05 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
1.000 | 3 | 30691459 | missense variant | G/A | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 3 | 30641799 | intron variant | A/G | snv | 0.66 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 30657290 | intron variant | G/A | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 3 | 30691426 | stop gained | C/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 3 | 30674109 | missense variant | G/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 3 | 30688433 | frameshift variant | CT/- | del |
|
0.700 | 0 | |||||||||||||
|
3 | 30672342 | missense variant | G/A;T | snv | 1.0E-03; 3.5E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | ||||||||||||
|
1.000 | 3 | 30674121 | missense variant | A/G;T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 3 | 30691424 | frameshift variant | T/- | del |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.040 | 3 | 30620836 | intron variant | C/G | snv | 0.72 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |